<p>MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway

Published:2020-07 Issue: Volume:Volume 13 Page:7493-7502
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Cao Shengya,Li Longfei,Li Jia,Zhao Hongying

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference31 articles.

1. Cancer statistics, 2014

2. Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

3. Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline

4. EGFR testing in lung cancer is ready for prime time

5. Targeting the epidermal growth factor receptor

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells;Cancer Cell International;2024-05-10

2. Copy number variation analysis identifies MIR9-3 and MIR1299 as novel miRNA candidate genes for CAKUT;Pediatric Nephrology;2024-04-24

3. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer;Pathology - Research and Practice;2024-01

4. MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression;Cellular and Molecular Biology;2023-10-31

5. CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis;International Journal of Biological Macromolecules;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3